Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865848/0/en/Inhibikase-Therapeutics-Issues-Letter-to-Shareholders-and-Provides-Update-on-Development-Programs.html
https://www.globenewswire.com/news-release/2024/04/03/2856913/0/en/Inhibikase-Therapeutics-Announces-Pre-IND-Meeting-with-the-FDA-for-IkT-001Pro-in-Pulmonary-Arterial-Hypertension.html
https://www.globenewswire.com/news-release/2024/03/27/2853623/0/en/Inhibikase-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Highlights-Recent-Activity.html
https://www.globenewswire.com//news-release/2024/03/07/2842246/0/en/Inhibikase-Therapeutics-to-Provide-Trial-Update-for-Risvodetinib-at-the-2024-International-Conference-on-Alzheimer-s-and-Parkinson-s-Diseases-and-Related-Neurological-Disorders.html
https://www.globenewswire.com//news-release/2024/02/28/2837410/0/en/Inhibikase-Therapeutics-Announces-Full-Outcomes-of-its-Pre-NDA-Meeting-with-the-FDA-for-IkT-001Pro.html
https://www.globenewswire.com//news-release/2024/02/07/2825103/0/en/Inhibikase-Therapeutics-Announces-Preliminary-Outcomes-of-its-Pre-NDA-Meeting-with-the-FDA-on-the-Pathway-for-Approval-for-IkT-001Pro-in-Blood-and-Gastrointestinal-Cancers.html
https://www.globenewswire.com/news-release/2024/01/29/2818972/0/en/Inhibikase-Therapeutics-Announces-Publication-Highlighting-Results-from-its-Phase-1-Studies-with-Risvodetinib.html
https://www.globenewswire.com//news-release/2024/01/16/2810310/0/en/Inhibikase-Therapeutics-Announces-Planned-Retirement-of-Chief-Financial-Officer-Joseph-Frattaroli.html
https://www.globenewswire.com//news-release/2023/12/19/2798525/0/en/Inhibikase-Therapeutics-Issues-Letter-to-Shareholders-and-Provides-Update-on-Development-Programs.html
https://www.globenewswire.com//news-release/2023/12/04/2790033/0/en/Inhibikase-Therapeutics-Granted-Pre-NDA-Meeting-with-the-FDA-for-IkT-001Pro.html